Back to discover
Drug

Inositol

In clinical development
Emerging researchLate-stage development
Also known as Amino-Cerv, Inositech, L-myo-Inositol, Pregnitude+4 more

Amino-Cerv, Inositech, L-myo-Inositol, Pregnitude, meso-Inositol, myo-inositol, 1,2,3,5/4,6-cyclohexanehexol, cis-1,2,3,5-trans-4,6-cyclohexanehexol.

1
Research papers
2
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder

Clinical trial2023-10-04Withdrawn · ClinicalTrials.gov

The human milk component <i>myo</i>-inositol promotes neuronal connectivity.

Research2023-07-11Proceedings of the National Academy of Sciences of the United States of America

A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania

Clinical trial2023-02-23Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Inositol
Aliases & brands
Amino-CervInositechL-myo-InositolPregnitudemeso-Inositolmyo-inositol1,2,3,5/4,6-cyclohexanehexolcis-1,2,3,5-trans-4,6-cyclohexanehexol
RxNorm CUI
5833
ChEMBL ID
CHEMBL1222251
ATC codes
A11HA07
UNII
4L6452S749

Clinical trials

22 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
22
registered trials across all phases
LATEST COMPLETION 2026
2
Active studies
2
Recruiting
13
Late-stage (III+)
8
Completed
12
Discontinued
PHASE DISTRIBUTIONn = 22
Early Phase 12Phase 1 / 22Phase 25Phase 2 / 32Phase 32Phase 43Phase N / A6

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

The human milk component <i>myo</i>-inositol promotes neuronal connectivity.

Proceedings of the National Academy of Sciences of the United States of America · 2023 · 29 cites
Recent papers

The human milk component <i>myo</i>-inositol promotes neuronal connectivity.

Proceedings of the National Academy of Sciences of the United States of America · 2023 · 29 cites
Major research themes2
Breast Feeding1Milk, Human1
Journals, researchers & institutions
Top journals
  • Proceedings of the National Academy of Sciences of the United States of America1
Leading researchers
  • Biederer T1
  • Carbone BE1
  • Chowdhury D1
  • Hondmann D1
  • Israel E1
  • Kondratiuk I1
  • Kuang C1
  • Labhart B1
Leading institutions
free-text, unnormalised
  • Perinatal Institute1
  • Tufts University School of Medicine1
  • United States Department of Agriculture Human Nutrition Research Center on Aging1
  • Yale School of Medicine1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials